GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medclair AB (NGM:MCLR) » Definitions » 5-Year EBITDA Growth Rate

Medclair AB (NGM:MCLR) 5-Year EBITDA Growth Rate : 0.00% (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Medclair AB 5-Year EBITDA Growth Rate?

Medclair AB's EBITDA per Share for the three months ended in Mar. 2025 was kr0.07.

During the past 12 months, Medclair AB's average EBITDA Per Share Growth Rate was 134.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Medclair AB was 69.40% per year. The lowest was 2.80% per year. And the median was 34.25% per year.


Competitive Comparison of Medclair AB's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Medclair AB's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medclair AB's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Medclair AB's 5-Year EBITDA Growth Rate falls into.


;
;

Medclair AB 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Medclair AB  (NGM:MCLR) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Medclair AB 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Medclair AB's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Medclair AB Business Description

Traded in Other Exchanges
N/A
Address
Box 3113, Stockholm, SWE, 103 62
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes up to 99% of the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.

Medclair AB Headlines

No Headlines